NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 24 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $472,128 | +2.1% | 500,000 | 0.0% | 0.01% | +18.2% |
| Q2 2023 | $462,430 | -1.6% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $470,000 | +2.5% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $458,750 | -3.0% | 500,000 | 0.0% | 0.01% | -8.3% |
| Q3 2022 | $473,000 | +1.5% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $466,000 | -13.9% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $541,000 | -2.7% | 500,000 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $556,000 | -17.6% | 500,000 | 0.0% | 0.01% | -7.1% |
| Q3 2021 | $675,000 | -22.1% | 500,000 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $866,000 | +12.3% | 500,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $771,000 | -15.5% | 500,000 | 0.0% | 0.02% | -10.5% |
| Q4 2020 | $912,000 | +17.7% | 500,000 | 0.0% | 0.02% | -5.0% |
| Q3 2020 | $775,000 | +13.5% | 500,000 | 0.0% | 0.02% | +5.3% |
| Q2 2020 | $683,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 10,000,000 | $15,644,000 | 3.40% |
| Perceptive Advisors | 9,000,000 | $141,822,000 | 2.07% |
| DeepCurrents Investment Group LLC | 14,430,000 | $22,483,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,784,000 | 0.46% |
| Polar Asset Management Partners Inc. | 17,500,000 | $27,302,000 | 0.37% |
| ZAZOVE ASSOCIATES LLC | 1,320,000 | $2,063,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,000,000 | $24,947,000 | 0.22% |
| Context Capital Management, LLC | 500,000 | $768,000 | 0.17% |
| Context Partners Fund, L.P. | 500,000 | $768,000 | 0.17% |
| PFM Health Sciences, LP | 2,000,000 | $3,151,000 | 0.15% |